Event Date/Time: Sep 19, 2005
End Date/Time: Sep 20, 2005
Combination drug-device products are expected to total $9.5 billion by 2009. Many drug companies are partnering with medical device companies to formulate innovative combination products. The combination product offers the advantage of delivering drugs locally versus systematically to maximize dosage. From submission to post-approval, this conference prepares you for your development and commercialization efforts. This conference is co-located with IBC’s Medical Devices: Strategies for Success conference. For more information and to register for Drug/Device Combination or Medical Devices, visit www.IBCLifeSciences.com/3128; or call +1 508-616-5550 x1004.